Actinium Pharmaceuticals, Inc. (ATNM)

USD 1.16

(-4.92%)

Long Term Debt Summary of Actinium Pharmaceuticals, Inc.

  • Actinium Pharmaceuticals, Inc.'s latest annual long term debt in 2023 was 1.57 Million USD , down -24.53% from previous year.
  • Actinium Pharmaceuticals, Inc.'s latest quarterly long term debt in 2024 Q2 was 1.29 Million USD , down 0.0% from previous quarter.
  • Actinium Pharmaceuticals, Inc. reported annual long term debt of 2.08 Million USD in 2022, up 69333.33% from previous year.
  • Actinium Pharmaceuticals, Inc. reported annual long term debt of 3000.00 USD in 2021, down -99.04% from previous year.
  • Actinium Pharmaceuticals, Inc. reported quarterly long term debt of 1.29 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • Actinium Pharmaceuticals, Inc. reported quarterly long term debt of 1.95 Million USD for 2023 Q1, down -6.19% from previous quarter.

Annual Long Term Debt Chart of Actinium Pharmaceuticals, Inc. (2023 - 2006)

Historical Annual Long Term Debt of Actinium Pharmaceuticals, Inc. (2023 - 2006)

Year Long Term Debt Long Term Debt Growth
2023 1.57 Million USD -24.53%
2022 2.08 Million USD 69333.33%
2021 3000.00 USD -99.04%
2020 311 Thousand USD -54.42%
2019 682.31 Thousand USD 5009.41%
2018 13.35 Thousand USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD -100.0%
2009 68.51 Thousand USD 37.5%
2008 49.82 Thousand USD 38.57%
2007 35.95 Thousand USD 147.99%
2006 14.5 Thousand USD 0.0%

Peer Long Term Debt Comparison of Actinium Pharmaceuticals, Inc.

Name Long Term Debt Long Term Debt Difference
AIM ImmunoTech Inc. 495 Thousand USD -217.576%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Armata Pharmaceuticals, Inc. 82.3 Million USD 98.09%
Azitra, Inc. 563.69 Thousand USD -178.876%
Can-Fite BioPharma Ltd. 13 Thousand USD -11992.308%
Chromocell Therapeutics Corporation - USD -Infinity%
Calidi Biotherapeutics, Inc. 2.06 Million USD 23.689%
CEL-SCI Corporation 11.6 Million USD 86.451%
iBio, Inc. 3.5 Million USD 55.175%
Lineage Cell Therapeutics, Inc. 2.07 Million USD 24.058%
MAIA Biotechnology, Inc. - USD -Infinity%
Matinas BioPharma Holdings, Inc. 2.89 Million USD 45.699%
Navidea Biopharmaceuticals, Inc. 1.87 Million USD 16.013%
NovaBay Pharmaceuticals, Inc. 1.1 Million USD -41.877%
NanoViricides, Inc. - USD -Infinity%
Oragenics, Inc. - USD -Infinity%
BiomX Inc. 5.4 Million USD 70.9%
BiomX Inc. 5.4 Million USD 70.9%
Protalix BioTherapeutics, Inc. 4.62 Million USD 65.981%
Palatin Technologies, Inc. 163.78 Thousand USD -859.812%
Scorpius Holdings, Inc. 12.61 Million USD 87.537%